Neurological damages due to cocaine abuse;Complicaciones neurológicas por cocaína

Adicciones

Volumn 18, Issue SUPPL. 1, 2006, Pages 179-196

  Torres Hernández, Miguel Ángel ^a   Climent Díaz, Benjamín ^b  

^a Centro de Salud Nazaret   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

Agitation; Cocaine; Hyperthermia; Intoxication; Leukoencephalopathy; Neurological damage; Rabdomyolisis; Seizures; Stroke

Indexed keywords

CATECHOLAMINE; COCAINE;

AGITATION; BLEEDING; CARDIOVASCULAR SYSTEM; CEREBROVASCULAR ACCIDENT; COCAINE DEPENDENCE; DEMYELINATION; HUMAN; HYPERTENSION; HYPERTHERMIA; LEUKOENCEPHALOPATHY; MIGRAINE; NERVE STIMULATION; NEUROLOGIC DISEASE; REVIEW; RHABDOMYOLYSIS; SEIZURE; SEROTONIN SYNDROME; SEROTONINERGIC SYSTEM; STROKE; SYMPATHETIC NERVE; VASOCONSTRICTION;

EID: 33750934938     PISSN: 02144840     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (110)

1. Neiman J, Haapaniemi HM, Hillbom A. Neurological complications of drug abuse pathophysiological mechanisms. Eur J Neurol. 2000; 7: 595-606.
2. Nogué S, Picón M, Mestre G, Corcuera R. Urgencies en usuarios de cocaína. Med Integral. 2002; 39: 249-259.
3. Hollander JE, Hoffman RS. Cocaine. Goldfrank's Toxicologic Emergencies, 7th Ed, McGraw-Hill, New York, 2002.
4. Bolouri MR, Small GA. Cerebrovascular and cardiovascular complications of alcohol and sympathomimetic drug abuse. Med Clin North Am. 2005; 89: 1343-1358.
5. Bruno A. Cerebrovascular complications of alcohol and sympathomimetic drug abuse. Curr Neurol Neurosci Rep. 2003; 3: 40-45.
6. Gottschalk PC, Kosten TR. Cerebral perfusion defects in combined cocaine and alcohol dependence. Drug Alcohol Depend. 2002; 69: 95-104.
7. Benowitz NL. How is toxic cocaine? Ciba Found Sump. 1992; 166: 125-143.
8. Martí Vilalta JL, Arboix A. Infarto cerebral de tipo lacunar. En Castillo J, et al. Manual de enfermedades vasculares cerebrales. Prous Science. Barcelona. 1999: 121-129.
9. Muñón T, Gállego J. Neuropatología de la hemorragia cerebral. En Castillo J, et al. Manual de enfermedades vasculares cerebrales. Prous Science. Barcelona. 1999: 187-197.
10. Delgado G. Hemorragias intracerebrales. En Castillo J, et al. Manual de enfermedades vasculares cerebrales. Prous Science. Barcelona. 1999: 229-239
11. Serena J, Vila N. Ictus isquémico de etiología menos frecuente. En Castillo J, et al. Manual de enfermedades vasculares cerebrales. Prous Science. Barcelona 1999: 143-153.
12. Balcells M. Complicaciones orgánicas de la cocaina. Adicciones, Vol. 13 (Suplemento 2); 2001: 167-172.
13. Debien B, et al. Les complications cardiovasculaires aiguës de la cocaine. A propos de deux observations. An Fr Reanim. 2006.
14. Lucas CE. The impact of street drug son trauma care. J Trauma. 2005; 59: 57-60.
15. Wu YW et al. Perinatal arterial stroke: understanding mechanisms and outcomes. Semin Neurol. 2005; 25: 424-434.
16. O'Connor AD, et al. Cerebrovascular and cardiovascular complications of alcohol and sympathomimetic drug abuse. Med Clin North Am 2005; 89: 1343-1358.
17. González-Martínez F, et al. Stroke in young patients: a diagnostic challenge in the emergency room. Eur J Emerg Med. 2004; 11: 178-180.
18. Velasquez EM, et al. Cardiovascular complications associated with cocaine use. J La State Med Soc. 2004; 156: 302-310.
19. Johnson BA, et al. isradipine decreases the hemodynamic response of cocaine and methamphetamine, results from two human laboratory studies. Am J Hypertens. 2005; 18: 813-822.
20. Johnson BA, et al. Acute intravenous low-and-high-dose cocaine reduces quantitative global and regional cerebral blood flow in recently abstinent subjects with cocaine use disorder. J Cereb Blood Flow Metab. 2005; 25: 928-936
21. Bolouri MR, et al. Neuroimaging of hypoxia and cocaine-induced hippoocampal stroke. J Neuroimaging. 2004; 14: 290-291.
22. Su J, et al. Cocaine induces apoptosis in cerebral vascular muscle cells: potential roles in strokes and brain damage. Eur J Pharmacol. 2003; 482: 61-66.
23. Vallee JN, et al. Acute basilar artery occlusion treated by thromboaspiration in a cocaine and ecstasy abuser. Neurology. 2003; 61: 839-841.
24. Buttner A, et al. The neuropathology of cocaine abuse. Leg Med (Tokyo). 2003; 5: S240-S242.
25. Broderick JP, et al. Major risk factors for aneurysmal subarachnoid hemorrhage in the young modifiable. Stroke. 2003; 34: 1375-1381.
26. Pettiti DB, Sidney S, Quesenbury C, et al. Stroke and cocaine or amphetamine use. Epidemiology, 1998; 9: 596-600.
27. Noel B. Vascular complications of cocaine use. Stroke. 2002; 33: 1747-1749.
28. Noël B. Major risk factors for aneurismal subarachnoid haemorrhage in the young are modifiable Stroke. 2003; 34: 1375-1381
29. Feldmann E, Broderick JP, et al. Major risk factors for intracerebral haemorrhage in the young are modifiable Stoke. 2005; 36: 1881-1885.
30. Blanco M, Díez-Tejedor E, Vivancos F, Barreiro P. Cocaína y enfermedad cerebrovascular en adultos jóvenes. Rev Neurol. 1999; 29: 796-800.
31. Johnson BA, Dawes MA, Roache JD, Wells LT, Ait-Daoud N, Mauldin JB, Wang Y, Lancaster JL, Fox PT. Acute intravenous low- and high-dose cocaine reduces quantitative global and regional cerebral blood flow in recently abstinent subjects with cocaine use disorder. J Cereb Blood Flow Metab. 2005; 25: 928-936.
32. Herning RI, Better W, Nelson R, Goreli D, Cadet JL. The regulation of cerebral blood flow during intravenous cocaine administration in cocaine abusers. Ann N Y Acad Sci. 1999; 890: 489-494.
33. Herning RI, King DE, Beter WE, Cadet JL. Neurovascular deficits in cocaine abusers. Neuropsychopharmacology. 1999; 21: 110-118.
34. Fredericks RK, Lefkowitz DS, Challa VR. Cerebral vasculitis associated with cocaine abuse. Stroke. 1991; 22: 1437-1439
35. O'Connor AD, Rusyniak DE, Bruno A. Neuroimaging of hypoxia and cocaine-induced hipocampal stroke. J Neuroimaging. 2004; 14: 290-291.
36. Bolouri MR, Small GA. Neuroimaging of hypoxia and cocaine-induced hipocampal stroke. J Neuroimaging. 2004; 14: 290-291.
37. Bartzokis G, Beckson M, Hance DB, Lu PH, Foster JA, Mintz J, Ling W, Bridge P. Magnetic resonance imaging evidence of "silent" cerebrovascular toxicity in cocaine dependence. Biol Psychiatry. 1999; 45: 1203-1211.
38. Lang CJ. The use of neuroimaging techniques for clinical detection of neurotoxicity: a review. Neurotoxicology. 2000; 21: 847-55.
39. Kaufman MJ, Levin JM, Ross MH, Lange N, Rose SL, Ukes TJ, Mendelson JH, Lukas SE, Cohen BM, Renshaw PF. Cocaine-induced cerebral vasoconstriction detected in humans with magnetic resonance angiography. Jama. 1998; 279: 376-380.
40. Heesch CM, Wilhelm CR, Ristich J, Adnane J, Bontempo FA, Wagner WR. Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans. Heart. 2000; 83: 688-695.
41. Nanda A, Vannenmreddy PS, Polin RS, Willis BK. Intracranial aneurysm and cocaine abuse analysis of prognostic indicators. Neurosurgery. 2000; 46: 1063-1069.
42. Conways JE, Tamargo RF. Cocaine use is an independent risk factor for cerebral vasospasm after aneurismal subarachnoid haemorrhage. Stroke. 2001; 32: 2338.
43. McEvoy AW, Kitchen ND, Thomas DG. Intracerebral haemorrhage and drug abuse in young adults. BR J Neurosurg. 2000; 14: 449-454.
44. Suarez JL, Tarr RW, Selman WR. Aneurismal subarachnoid haemorrhage. N Engl J Med. 2006; 354: 387-396.
45. González F, Navarro S, Oliete E, Sánchez J, Ballester MR, Estévez E. Stroke in young patients a diagnostic challenge in the emergency room. Eur J Emerg Med. 2005; 11: 178-180.
46. McEvoy A, Kitchen ND. Intracerebral haemorrhage in young adults: the emerging drug misuse. BMJ. 2000; 320: 1322-1324.
47. Arboix A, Martí-Vilalta JL. New concepts in lacunar stroke aetiology: the constellation os small-vessel arterial disease. Cerebrovasc disease 2004; 17: 58-62.
48. Qureshi AI, Suri MF, Guterman LR, Hopkins LN. Cocaine use and the likelihood of nonfatal myocardial infarction and stroke: data from the Third National Health and Nutrition Examination Survey. Circulation. 2001; 103: 502-506.
49. Bankole AJ, Michael DD, Ruiz P, Ait-Daoud N. Treatment advances for cocaine-induced ischemic stroke focus on dyhidropyridine-class calcium channel antagonists. Am J Psychiatry. 2001; 1191-1198.
50. Kosten TR. Pharmacotherapy of cerebral ischemia in cocaine dependence. Drug Alcohol Depend. 1998; 49: 133-144.
51. Williams JB, et al. Hemodynamic response profile predicts susceptibility to cocaine-induce toxicity. Eur J Pharmacol. 2003; 464: 189-196.
52. Auer J et al. Subarachnoid haemorrhage with ecstasy abuse in young adult. Neurol Sci. 2002; 23: 199-201.
53. Bruno A. Cerebrovascular complications of alcohol and sympathomimetic drug abuse. Curr Neurol Neurosci Rep. 2003; 3: 40-45.
54. Klauser HA, et al. Infrequent causes of stroke. Emerg Med Clin North Am. 2002; 20: 657-670.
55. Querot E, et al. Acute complications in cocaine users. Ann Med Intern (Paris). 2002; 153: 1527-1531.
56. Johnson BA, et al. Treatment advances for cocaine induced ischemic stroke: focus on dyhidropiridine-class calcium channel antagonists. Am J Psychiatry. 2001; 158: 1191-1198.
57. Rey A. Crisis epilépticas y epilepsia. En Rey A. Urgencias neurológicas. Diagnóstico y tratamiento. Ediciones Doyma. Barcelona. 2000.
58. Pascual Leone A, Dhuna A, Altafulla I, Anderson DC. Cocaine-induced seizures. Neurology. 1990; 40: 404-407.
59. Mott SH, Packer RJ, Soldin SJ. Neurological Manifestations of cocaine exposure in childhood. Pediatrics. 1994; 93: 557-560.
60. Koppel BS, Samkoff L, Daras M. Relation of cocaine use to seizures and epilepsy. Epilepsia. 1996; 37: 875-878.
61. Zullino DF, Khazaal Y, Hattenschwiler J, Borgeat F, Besson J. Anticonvulsivant drugs in the treatment of substance withdrawal. Drugs Today. 2004; 40: 603.
62. Rey A. Cefaleas. En Rey A. Urgencias neurológicas, diagnóstico y tratamiento. Ediciones Doyma. Barcelona. 2000.
63. Mossman SS, Goadsby PJ. Cocaine abuse simulating the aura of migraine. J. Neurol Neurosurg Psychiatry. 1992; 55.
64. Dhuna A, Pascual Leone A, Belgrade M. Cocaine-related vascular headaches. J Neurol Neurosurg Psychiatry. 1991; 54: 807-812.
65. Penarrocha M, Bagan JV, Penarrocha MA, Silvestre FJ. Cluster headache and cocaine use. Oral Surg Oral Med Oral Pathol Oral Radiol endod 2000 Sep; 90: 271-274.
66. Daras M, Koppel BS, Atos-Radzion E. Cocaine-induced choreoathetoid movements ("crack dancing"). Neurology. 1994; 44: 751-2.
67. Supervía A, Llobera J, Cuadrado E, Del Baño F. Movimientos coreiformes tras consumo de crack: el crack dancing. Med Clin (Barc) 2006; 126: 555.
68. Rodnitzky RL. Keyser DL. Neurologic complications of drugs. Tardive dyskinesias neuroleptic malignant sindrome, and cocaine-related síndromes. Psychiatr Clin North Am. 1992; 15: 491-510.
69. La Monaca G, Donatelli A, Katz JL. A case of mutism subsequent to cocaine abuse. J Subst Abuse Treat. 1999; 17: 109-112.
70. Franklin JE, Levenson JL, McCann-Katz EF. Trastornos relacionados con sustancias. En Levenson JL. Tratado de Medicina Psicosomética. Tomo I. Ars Médica. Barcelona. 2006.
71. Gingrich JA, Rudnick-Levin F, Almeida C, Innes L, Schneider H. Cocaine and catatonia. Am J Psychiatry. 1998; 155: 1629.
72. Weiner WJ, Rabinstein A, Levin B, Weiner C, Shulman LM. Cocaine-induced persistent dyskinesias. Neurology. 2001; 56: 964-965.
73. Bartzokis G, Beckson M, Wirsing DA, Lu PH, Foster JA, Mintz J. Choreoathetoid movements in cocaine dependents. Biol Psychiatry. 1999; 45: 1630-1635.
74. Daras M, Koppel BS, Atos-Radzion E. Cocaine-induced Choreoathetoid movements ("crack-dancing"). Neurology. 1994; 44: 751-752.
75. Filley CM, Kleinschmidt-DeMasters BK. Toxic leukoencephalopathy. New Engl J Med. 2001; 345: 425-443.
76. Nuytten D, Wyffels E, Michiels K, Ferrante M, Verbracken H, Dalemans R, Baeck E, Cras P. Drug-induced spongiform leucoencephalopathy, a case report with review of the literature. Acta Neurol Belg, 1998; 98: 32-35.
77. Lomax P, Daniel KA. Cocaine and body temperature effect of exercise at high ambient temperature. Pharmacology. 1993; 46: 164-172.
78. Crandall CG, Vongpatanasin W, Victor RG. Mechanism of cocaine-induced hyperthermia in humans. Ann Inter Med. 2002; 136: 785-791.
79. Schier JG, Hoffman RS, Nelson LS. Cocaine and body temperature regulation. Ann Intern Med 2002; 137: 855.
80. Rosenberg J et al. Hyperthermia associated with drug intoxication. Crit Care Med. 1986; 14: 964-969.
81. Merigian KS, Roberts JR. Cocaine intoxication: hyperpyrexia, rhabdomiolysis and acute renal failure. J Toxicol Clin Toxicol. 1987; 25: 135-148.
82. Menashe PI, Gottlieb JE. Hyperthermia, rhabdomyolisis, and mioglobinuric renal failure after recreational use of cocaine. South Med J. 1988; 81: 379-381.
83. Daras M, Kakkouras L, Tuchman AJ, Koppel BS, Wetli CV, Mash D, Karch SB. Cocaine-associated agitated delirium and the neuroleptic malignant syndrome. Am J Emerg Med. 1996; 14: 425-428.
84. Wetli CV, Mash D, Karch SB. Cocaine-associated agitated delirium and the neuroleptic malignant syndrome. Am J Emerg Med. 1996; 14: 425-428.
85. Loghmanee F, Tobak M. Fatal malignant hyperthermia associated with recreational cocaine and ethanol abuse. Am J Forensic Med Pathol. 1986; 7: 246-248.
86. Fernández-Quero L, Cabrerizo P, Canal MI, Frias I. Fatal poisoning by the rupture of intestinal bags of cocaine. Rev Esp Anestesiol Reanim. 1993; 40: 39-40.
87. González LP. Cocaine alters body temperature and behavioural thermoregulatory responses. Neuroreport. 1993; 4: 106-108.
88. Merigian Ks, et al. Adrenergic crisis from crack cocaine ingestion: report of five cases. J Emerg Med. 1994; 12: 485-490.
89. Calaway CW, Clark RF. Hyperthermia in psychoestimulants overdose. Ann Emerg Med. 1994; 24: 68-76.
90. Sato N, Brum JM, Mitsumoto H, DeBoer GE. Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia. Can J Anaesth. 1995; 42: 158-162.
91. Daras M, Kakkouras L, Tuchman AJ, Koppel BS. Rhabdomyolisis and hyperthermia after cocaine abuse: a variant of the neuroleptic malignant syndrome. Acta Neurol Scand. 1995; 92: 161-165.
92. Ruttemberg AJ, Lawler-Heavner J, Yin M, Wetli Cv, Hearn WL, Mash DC. Fatal excited delirium following cocaine use: epidemiologic findings provide new evidence for mechanisms of cocaine toxicity. J Forensic Sci. 1997; 42: 25-31.
93. Kiyatkin EA. Brain Hyperthermia during physiological and pathological conditions: causes, mechanisms, and functional implications. Curr Neurovasc Res. 2004; 1: 77-90.
94. Kiyatkin EA. Brain hyperthermia as physiological and pathological phenomena. Brain Res Brain Res Rev. 2005; 50: 27-56.
95. Blaho K, Winbery S, Park L, Logan B, Karch SB, Barker LA. Cocaine metabolism in hyperthermic patients with excited delirium. Cli forensic Med. 2000; 7: 71-76.
96. Blech-Hermoni Y, Kiyatkin EA. 2004. State-dependent action of cocaine on brain temperature and movement activity: implications for movement sensitization. Pharmacol Biochem Behav. 2004; 77: 823-837.
97. Martínez M, Devenport L, Saussy J, Martínez J. Drug associated heat stroke. South Med J. 2002; 95: 799-802.
98. Crandall CG, Vongpatanasin W, Victor RG. Mechanism of cocaine-induced hyperthermia in humans. Ann Intern Med. 2002; 137: 855-856.
99. Horst E, Bennett RL, Barrett O. Recurrent rhabdomyolisis in association with cocaine use. South Med J. 1991; 78: 269-282.
100. Singhal PC, Rubin RB, Peters A. Rhabdomyolisis and acute renal failure associated with cocaine abuse. J Toxicol Clin Toxicol. 1990; 28: 321-330.
101. Ruttenberg AJ, McAnally HB, Wetli CV. Cocaine-associated rhabdomyolisis and excited delirium: different stages of the same syndrome. Am J Forensic Med Pathol. 1999; 20: 120-127.
102. Vallina E, Suárez R, García A, Arribas JM. Rabdomiolisis syndrome and hyperthermia secondary to cocaine and/or ecstasy consumption. Report of 2 new cases and review of the problem. An Med Interna. 2002; 19: 85-88.
103. Tanvetyanon T, Dissin J, Selcer UM. Hyperthermia and chronic pancerebellar syndrome after cocaine abuse. Arch Intern Med. 2001; 161: 608-610.
104. Tanen DA, Graeme KA, Curry SC. Crack cocaine ingestion with prolonged toxicity requiring electrical pacing. J Toxicol clin Toxicol. 2000; 38: 653-657.
105. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005; 1112-1120.
106. Kish SJ, Kalasinsky KS, Furukawa Y, Guttman M, Ang L, Li L, Adams V, Reiber G, Anthony RA, Anderson W, Smialek J, Distefano L. Brain cholyne acetyltransferase activity in chronic, human users of cocaine, methamphetamine, and heroin. Mol Psychiatry. 1999; 4: 26-32.
107. Klein C, Balash Y, Pollak L, Hiss J, Rabey MJ. Body packer: cocaine intoxication, causing death, masked by concomitant administration of major tranquilizers. Eur J Neurol. 2000; 7: 555-558.
108. Tooney R, Lyons MJ, Eisen SA, et al. A twin study of the neuropsychological consequences of stimulant abuse. Arch Gen Psychiatry. 2003; 60: 303-310.
109. Bolla KI, Funderburk FR, Cadet JL. Differential effects of cocaine and cocaine alcohol on neurocognitive performance. Neurology. 2000; 54: 2285-2292.
110. June R, Aks SE, Keys N. Medical outcome of cocaine bodystuffers. J Emerg Med. 2000; 18: 221-224.